Phase 3 Angina Pectoris Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina
Chronic Stable Angina Pectoris
Tasly Pharmaceuticals, Inc.765 enrolled1 locationNCT03789552
Recruiting
Phase 2Phase 3
Efficacy of Targeted Medical Therapy in Angina and Nonobstructive Coronary Arteries
Angina PectorisMicrovascular AnginaVasospastic Angina+1 more
Stanford University150 enrolled1 locationNCT06424834